BioTime Takes Strategic Step Forward In Developing Regenerative Technology
BioTime Takes Strategic Step Forward In Developing Regenerative Technology
Tuesday, BioTime Inc. (BTIM) announced a peer-reviewed scientific
publication on the reversal of developmental aging in normal human
cells , taking a strategic step forward in the development of its
ReCyte iPS Technology. Shares touched a new intraday high of $8.42
for the year and is trading at $7.52, an increase of nearly 30%
from the previous days close.view original article
